Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protective effect of interferon on the liver solved – targeted treatment approaches available, soon?

06.11.2013
Type I interferons are used for treatment of viral hepatitis because of their antiviral and thus, hepatoprotective effects. Treatment with interferon, however, involves severe adverse effects.

Researchers at the Paul-Ehrlich-Institut have now found the mechanism of how interferon protects the liver. In this context, specific suppressor cells and the balance between the inflammation mediator interleukin-1beta and its inhibitor, the interleukin-1 receptor antagonist play a central role. The findings may provide approaches to a more specific therapy with fewer adverse effects.


Liver histology of mice after treatment with poly(I:C). Control mice (WT) are protected by an interferon-mediated effect, mice without the interferon receptor (IFNAR-/-) develop severe liver damage.

Source: Paul-Ehrlich-Institut

Hepatology reports on the research results in its online prepublication (DOI:10.1002/hep.26915).

Type I interferons are mainly associated with their immunostimulatory, antiviral, and antitumoral effects. However, they also have anti-inflammatory properties. Thus, in patients with a liver inflammation due to a chronic hepatitis-C virus infection, interferon may improve the condition of the liver. This can also be observed when, thanks to treatment, the viral burden is negligible already.

PD (associate professor) Dr Zoe Waibler, head of a temporary research group at the Paul-Ehrlich-Institut (PEI), and co-workers have studied the mechanism which results in this protective effect. For the study not a virus but poly(I:C), an artificial double-stranded RNA which mimics a viral infection, was used. Poly(I:C) was applied to interferon receptor-deficient (IFNAR-deficient) mice and genetically unmodified control mice.

In IFNAR-deficient mice, the treatment with poly(I:C) induced a severe acute liver damage with necrosis, while the control animals were protected. Similarly to human liver inflammations, serum levels of the enzyme alanine aminotransferase also increased upon poly(I:C) treatment of IFNAR-deficient mice, while those of the control mice did not.

In collaboration with Professor Christian Bogdan, Institute of Clinical Microbiology, Immunology, and Hygiene of the University Hospital of Erlangen, the team of PEI researchers identified certain suppressor cells ("myeloid derived suppressor cells", MDSC) as mediators of protection: Upon type I interferon expression, these cells infiltrate the liver, where they convey the protective effect. The team achieved this by switching off the interferon receptor on individual cell types and studying specific surface markers.

Dr Waibler and co-workers were able to show that these suppressor cells influence the balance between the pro- inflammatory cytokine interleukin-1beta (IL-1beta) and its naturally occurring inhibitor, anti-inflammatory interleukin-1 receptor antagonist (IL-1RA) in the liver: For IFNAR-deficient mice, there was a drastic shift toward inflammatory IL-1beta upon poly(I:C) treatment, while for the control mice, the shift occurred in the direction of the anti-inflammatory IL-1RA.

The fact that IL-1beta and IL-1RA indeed induced the inflammatory or protective effects, respectively, in the liver could be proved by Dr Waibler and co-workers by administrating IL-1RA to IFNAR-deficient mice, which prevented the liver damage induced by poly(I:C). Although interferon could not mediate the protective effect here, due to the missing interferon receptor, the downstream effects, normally mediated by interferon, was restored by the administration of IL-1RA. Likewise, liver functions improved in IFNAR-deficient mice if the inflammatory cytokine IL-1beta was neutralized by adding an anti-IL-1beta antibody.

"Interferons have extremely versatile effects by regulating up to 300 genes, thus bringing about a great variety of effects. Only a minor part of them is responsible for this effect on the liver. Maybe an organ-specific therapy would be possible here", explained Dr Waibler with regard to a potential clinical use of these results. Biotechnologically engineered IL-1RA is used in the treatment of rheumatoid arthritis. In addition, there is a genetically engineered monoclonal antibody directed against IL-1beta, which is used in patients with a particular genetic defect.

The PEI researchers also have an explanation for the fact that the suppressor cells in the control mice infiltrate the liver: Based on experimental results, they assume that interferons switch on a particular chemokine in the liver, which attracts the suppressor cells (MDSC).

"Many immunological processes are not fully understood, yet. With our fundamental research, we contribute to developing approaches to therapies that are effective but at the same time cause as few adverse effects as possible", emphasised Professor Cichutek, president of the Paul-Ehrlich-Institut.

Original publication

DOI:10.1002/hep.26915; unedited version

Conrad E, Resch TK, Gogesch P, Kalinke U, Bechmann I, Bogdan C, Waibler Z (2013): Protection against RNA-induced liver damage by myeloid cells requires type I IFN and IL-1 receptor antagonist. Hepatology [Epub ahead of print].

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and veterinary vaccines. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the varied and many tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://onlinelibrary.wiley.com/doi/10.1002/hep.26915/abstract
Abstract of the publication (accepted, unedited)
http://www.pei.de/EN/information/journalists-press/press-releases/2013/12-protective-effect-interferon-liver-solved.html

Press Release on the Paul-Ehrlich-Institut Website

Dr. Susanne Stöcker | idw
Further information:
http://www.pei.de

More articles from Life Sciences:

nachricht Discovery of a Key Regulatory Gene in Cardiac Valve Formation
24.05.2017 | Universität Basel

nachricht Carcinogenic soot particles from GDI engines
24.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>